Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens

被引：94

作者：

Jarvest, RL

Berge, JM

Berry, V

Boyd, HF

Brown, MJ

Elder, JS

Forrest, AK

Fosberry, AP

Gentry, DR

Hibbs, MJ

Jaworski, DD

O'Hanlon, PJ

Pope, AJ

Rittenhouse, S

Sheppard, RJ

Slater-Radosti, C

Worby, A

机构：

[1] GlaxoSmithKline, Harlow CM19 5AW, Essex, England

[2] GlaxoSmithKline, Collegeville, PA 19426 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2002年 / 45卷 / 10期

关键词：

D O I：

10.1021/jm025502x

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Potent nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase have been derived from a file compound high throughput screening hit. Optimized compounds show excellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics. Compound II demonstrated in vivo efficacy in an S. aureus rat abscess infection model.

引用

页码：1959 / 1962

页数：4

共 50 条

[31] Antibacterial Efficacy of Cold-Sprayed Copper Coatings against Gram-Positive Staphylococcus aureus and Gram-Negative Escherichia coli
Hutasoit, Novana
Topa, Sanjida Halim
Javed, Muhammad Awais
Rashid, Rizwan Abdul Rahman
Palombo, Enzo
Palanisamy, Suresh
MATERIALS, 2021, 14 (22)
[32] Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens
Brown, Dean G.
May-Dracka, Tricia L.
Gagnon, Moriah M.
Tommasi, Ruben
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (23) : 10144 - 10161
[33] Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram-Positive Pathogens
Steed, Molly E.
Rybak, Michael J.
PHARMACOTHERAPY, 2010, 30 (04): : 375 - 389
[34] Charged Nonclassical Antifolates with Activity Against Gram-Positive and Gram-Negative Pathogens
Scocchera, Eric
Reeve, Stephanie M.
Keshipeddy, Santosh
Lombardo, Michael N.
Hajian, Behnoush
Sochia, Adrienne E.
Alverson, Jeremy B.
Priestley, Nigel D.
Anderson, Amy C.
Wright, Dennis L.
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (07): : 692 - 696
[35] Characterization of an Antibacterial Agent Targeting Ferrous Iron Transport Protein FeoB against Staphylococcus aureus and Gram-Positive Bacteria
Shin, Minhye
Jin, Yerin
Park, Jinsub
Mun, Daye
Kim, Soo Rin
Payne, Shelley M.
Kim, Kyoung Heon
Kim, Younghoon
ACS CHEMICAL BIOLOGY, 2021, 16 (01) : 136 - 149
[36] In Vitro Antibacterial Activity Against Gram-positive and Gram-negative Pathogens in Asia - Tigecycline Evaluation Surveillance Trial (TEST)
Johnson, Jack
Johnson, B. M.
Bouchillon, S.
Stevens, T.
Hoban, D.
Dowzicky, M.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S79 - S79
[37] Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus
Corey, G. Ralph
Rubinstein, Ethan
Stryjewski, Martin E.
Bassetti, Matteo
Barriere, Steven L.
CLINICAL INFECTIOUS DISEASES, 2015, 60 (05) : 787 - 796
[38] Biochemical and structural characterization of chlorhexidine as an ATP-assisted inhibitor against type 1 methionyl-tRNA synthetase from Gram-positive bacteria
Lu, Feihu
Xia, Kaijiang
Su, Jingtian
Yi, Jia
Luo, Zhiteng
Xu, Jun
Gu, Qiong
Chen, Bingyi
Zhou, Huihao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 268
[39] Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive Pathogens
Xin, Bingyue
Zheng, Jinshui
Liu, Hualin
Li, Junhua
Ruan, Lifang
Peng, Donghai
Sajid, Muhammad
Sun, Ming
FRONTIERS IN MICROBIOLOGY, 2016, 7
[40] In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens
Pucci, Michael J.
Cheng, Jijun
Podos, Steven D.
Thoma, Christy L.
Thanassi, Jane A.
Buechter, Douglas D.
Mushtaq, Gohar
Vigliotti, Gerald A., Jr.
Bradbury, Barton J.
Deshpande, Milind
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1259 - 1267

← 1 2 3 4 5 →